SLC5A2 and allergic asthma: Considering that the chronic phase of allergic asthma was made by combined inflammatory responses of Th1, Th2, and Th17 cells and their cytokines [36,37,38,39,40], the anti-inflammatory effects of SGLT2 inhibitors may be an explanation mainly for the in vivo efficacy of SGLT2 inhibitors.